Tokyo - Delayed Quote JPY

COSMOS Pharmaceutical Corporation (3349.T)

14,110.00 +15.00 (+0.11%)
At close: May 17 at 3:15 PM GMT+9
Loading Chart for 3349.T
DELL
  • Previous Close 14,095.00
  • Open 14,015.00
  • Bid --
  • Ask --
  • Day's Range 13,990.00 - 14,175.00
  • 52 Week Range 13,060.00 - 17,440.00
  • Volume 274,900
  • Avg. Volume 198,350
  • Market Cap (intraday) 559.162B
  • Beta (5Y Monthly) 0.13
  • PE Ratio (TTM) 22.47
  • EPS (TTM) 627.90
  • Earnings Date Jul 8, 2024 - Jul 12, 2024
  • Forward Dividend & Yield 120.00 (0.85%)
  • Ex-Dividend Date May 30, 2024
  • 1y Target Est 16,858.20

COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, food, etc. in Japan. It also sells its products through online stores. The company was incorporated in 1983 and is headquartered in Fukuoka, Japan.

www.cosmospc.co.jp

5,290

Full Time Employees

May 31

Fiscal Year Ends

Recent News: 3349.T

Performance Overview: 3349.T

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

3349.T
13.36%
Nikkei 225
15.91%

1-Year Return

3349.T
0.45%
Nikkei 225
28.89%

3-Year Return

3349.T
5.81%
Nikkei 225
39.40%

5-Year Return

3349.T
62.19%
Nikkei 225
82.53%

Compare To: 3349.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 3349.T

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    559.16B

  • Enterprise Value

    551.42B

  • Trailing P/E

    22.47

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.60

  • Price/Book (mrq)

    2.49

  • Enterprise Value/Revenue

    0.59

  • Enterprise Value/EBITDA

    15.96

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.66%

  • Return on Assets (ttm)

    4.91%

  • Return on Equity (ttm)

    11.63%

  • Revenue (ttm)

    936.71B

  • Net Income Avi to Common (ttm)

    24.87B

  • Diluted EPS (ttm)

    627.90

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    18.45B

  • Total Debt/Equity (mrq)

    4.77%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 3349.T

Company Insights: 3349.T

Research Reports: 3349.T

People Also Watch